drugset / Trial / NCT03058263

Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose

NCT03058263

Phase 1/2 Completed 66 enrolled Indonesia University
RandomizedParallel-groupOpen-labelSupportive care

Summary

This study aimed to evaluate the effect of Neostigmine partial dose towards neuromuscular blockade of rocuronium

Timeline

Start
2016-10
Primary completion
2017-02-01
Completion
2017-02-28

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 0.02 mg

Indications

No indication recorded.